UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004697 |
|---|---|
| Receipt number | R000005592 |
| Scientific Title | A phase II study of Panitumumab combined with Irinotecan and S-1 as second line therapy in metastatic colorectal cancer patients with KRAS wild type |
| Date of disclosure of the study information | 2010/12/10 |
| Last modified on | 2023/12/19 09:25:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/12/09 19:45:48 | ||
| 2 | Update | 2016/06/10 09:35:15 | TEL Last name of contact person Last name of contact person Address Address TEL Name of primary person or sponsor Department Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2022/12/18 14:16:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Address TEL Personal name Personal name Address1 Tel1 Organization Organization Address Address Tel |
|
| 4 | Update | 2023/12/19 09:25:59 | Date of IRB Last follow-up date |
